spacer
home > white papers > Migration safe pharmaceutical labels improve patient safety - UPM Raflatac
WHITE PAPERS
logo_UPM_Raflat.jpg

UPM Raflatac

phone +358 2041 6143
web http://www.upmraflatac.com
email Tesomankatu 31, P.O. Box 53 33101 Tampere

Migration safe pharmaceutical labels improve patient safety

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Ubiquigent celebrates milestone anniversary of DUBprofiler™ compound profiling platform

 Dundee, UK, 14th December 2021 – Today, Ubiquigent Limited (Ubiquigent) celebrates the 10th anniversary of its DUBprofiler™ compound profiling platform, together with KSQ Therapeutics joining its expanding customer base.
More info >>


White Papers

Investigator Portals: Facilitating and Streamlining Communication & Collaboration with Study Sites

ArisGlobal

ArisGlobal LLC Investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management. Learn about five key areas of sponsor-investigator site interactions deserving of electronic communication and collaboration. Technology and design aspects are also covered.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement